1. Hoop M, Ribeiro AS, Rosch D, Weinand P, Mendes N, Mushtaq F, Chen XZ, Shen Y, Pujante CF, Puigmarti-Luis J, Paredes J, Nelson BJ, Pego AP, Pane S

Mobile Magnetic Nanocatalysts for Bioorthogonal Targeted Cancer Therapy ADVANCED FUNCTIONAL MATERIALS 28: ., 2018.  [Article] 

 doi: 10.1002/adfm.201705920.

 

2. Van Der Werf CS, Wabbersen TD, Hsiao NH, Paredes J, Etchevers HC, Kroisel PM, Tibboel D, Babarit C, Schreiber RA, Hoffenberg EJ, Vekemans M, Zeder SL, Ceccherini I, Lyonnet S, Ribeiro AS, Seruca R, Te Meerman GJ, van Ijzendoorn SC, Shepherd IT, Verheij JB, Hofstra RM

CLMP is required for intestinal development, and loss-of-function mutations cause congenital short-bowel syndrome. Gastroenterology 142: 453-462.e3, 2012.  [Article] 

 doi: 10.1053/j.gastro.2011.11.038 PMID: 22155368.

 

3. Tavares S, Vieira AF, Taubenberger AV, Araújo M, Martins NP, Brás-Pereira C, Polónia A, Herbig M, Barreto C, Otto O, Cardoso J, Pereira-Leal JB, Guck J, Paredes J, Janody F

Actin stress fiber organization promotes cell stiffening and proliferation of pre-invasive breast cancer cells. Nature communications 8: 15237, 2017.  [Article] 

 doi: 10.1038/ncomms15237 PMID: 28508872.

 

4. Marteil G, Guerrero A, Vieira AF, de Almeida BP, Machado P, Mendonça S, Mesquita M, Villarreal B, Fonseca I, Francia ME, Dores K, Martins NP, Jana SC, Tranfield EM, Barbosa-Morais NL, Paredes J, Pellman D, Godinho SA, Bettencourt-Dias M

Over-elongation of centrioles in cancer promotes centriole amplification and chromosome missegregation. Nature communications 9: 1258, 2018.  [Article] 

 doi: 10.1038/s41467-018-03641-x PMID: 29593297.

 

5. van der Werf C, Wabbersen T, Hsiao N, Paredes J, Etchevers H, Kroisel P, Tibboel D, Babarit C, Babarit C, Schreiber R, Hoffenberg E, Vekemans M, Zeder S, Ceccherini I, Lyonnet S, Ribeiro Ana S., Seruca R, Meerman G, IJzendoorn S, Shepherd I, Verheij J, Hofstra R

Mutations in CLMP cause Congenital Short Bowel Syndrome, pointing to its major role in intestinal development Gastroenterology  1, 2011.  [] 

.

 

6. Caldeira J, Simões-Correia J, Paredes J, Pinto MT, Sousa S, Corso G, Marrelli D, Roviello F, Pereira PS, Weil D, Oliveira C, Casares F, Seruca R

CPEB1, a novel gene silenced in gastric cancer: a Drosophila approach. Gut 61: 1115-23, 2012.  [Article] 

 doi: 10.1136/gutjnl-2011-300427 PMID: 22052064.

 

7. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, Costa AM, Simões-Correia J, Oliveira MJ, Pinheiro H, Pinho SS, Mateus R, Reis CA, Leite M, Fernandes MS, Schmitt F, Carneiro F, Figueiredo C, Oliveira C, Seruca R

Epithelial E- and P-cadherins: Role and clinical significance in cancer. Biochimica et Biophysica acta-Reviews on Cancer 1826: 297-311, 2012.  [Review] 

 doi: 10.1016/j.bbcan.2012.05.002 PMID: 22613680.

 

8. Velho S, Oliveira C, Paredes J, Sousa S, Leite M, Matos P, Milanezi F, Ribeiro AS, Mendes N, Licastro D, Karhu A, Oliveira MJ, Ligtenberg M, Hamelin R, Carneiro F, Lindblom A, Peltomaki P, Castedo S, Schwartz S, Jordan P, Aaltonen LA, Hofstra RM, Suriano G, Stupka E, Fialho AM, Seruca R

Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours. Human molecular genetics 19: 697-706, 2010.  [Article] 

 doi: 10.1093/hmg/ddp536 PMID: 19955118.

 

9. Albergaria A, Ribeiro AS, Pinho S, Milanezi F, Carneiro V, Sousa B, Sousa S, Oliveira C, Machado JC, Seruca R, Paredes J, Schmitt F

ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation. Human molecular genetics 19: 2554-66, 2010.  [Article] 

 doi: 10.1093/hmg/ddq134 PMID: 20385540.

 

10. Vieira AF, Ricardo S, Ablett MP, Dionísio MR, Mendes N, Albergaria A, Farnie G, Gerhard R, Cameselle-Teijeiro JF, Seruca R, Schmitt F, Clarke RB, Paredes J

P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer. Stem cells (Dayton, Ohio) 30: 854-64, 2012.  [Article] 

 doi: 10.1002/stem.1075 PMID: 22389315.

 

11. Paredes J, Stove C, Stove V, Milanezi F, Van Marck V, Derycke L, Mareel M, Bracke M, Schmitt F

P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells. Cancer research 64: 8309-17, 2004.  [Article] 

 doi: 10.1158/0008-5472.CAN-04-0795 PMID: 15548699.

 

12. Van Marck V, Stove C, Van Den Bossche K, Stove V, Paredes J, Vander Haeghen Y, Bracke M

P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma. Cancer research 65: 8774-83, 2005.  [Article] 

 doi: 10.1158/0008-5472.CAN-04-4414 PMID: 16204047.

 

13. Ribeiro AS, Albergaria A, Sousa B, Correia AL, Bracke M, Seruca R, Schmitt FC, Paredes J

Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. Oncogene 29: 392-402, 2010.  [Article] 

 doi: 10.1038/onc.2009.338 PMID: 19901964.

 

14. Pinho SS, Reis CA, Paredes J, Magalhães AM, Ferreira AC, Figueiredo J, Xiaogang W, Carneiro F, Gärtner F, Seruca R

The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. Human molecular genetics 18: 2599-608, 2009.  [Article] 

 doi: 10.1093/hmg/ddp194 PMID: 19403558.

 

15. Ribeiro AS, Carvalho FA, Figueiredo J, Carvalho R, Mestre T, Monteiro J, Guedes AF, Fonseca M, Sanches J, Seruca R, Santos NC, Paredes J

Atomic force microscopy and graph analysis to study the P-cadherin/SFK mechanotransduction signalling in breast cancer cells. Nanoscale 8: 19390-19401, 2016.  [Article] 

 doi: 10.1039/c6nr04465d PMID: 27847941.

 

16. Ribeiro AS, Sousa B, Carreto L, Mendes N, Nobre AR, Ricardo S, Albergaria A, Cameselle-Teijeiro JF, Gerhard R, Söderberg O, Seruca R, Santos MA, Schmitt F, Paredes J

P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model. The Journal of pathology 229: 705-18, 2013.  [Article] 

 doi: 10.1002/path.4143 PMID: 23180380.

 

17. Moniz S, Martinho O, Pinto F, Sousa B, Loureiro C, Oliveira MJ, Moita LF, Honavar M, Pinheiro C, Pires M, Lopes JM, Jones C, Costello JF, Paredes J, Reis RM, Jordan P

Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness. Human molecular genetics 22: 84-95, 2013.  [Article] 

 doi: 10.1093/hmg/dds405 PMID: 23035050.

 

18. Vieira AF, Dionísio MR, Gomes M, Cameselle-Teijeiro JF, Lacerda M, Amendoeira I, Schmitt F, Paredes J

P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 30: 698-709, 2017.  [Article] 

 doi: 10.1038/modpathol.2016.232 PMID: 28084338.

 

19. Vieira AF, Ribeiro AS, Dionísio MR, Sousa B, Nobre AR, Albergaria A, Santiago-Gómez A, Mendes N, Gerhard R, Schmitt F, Clarke RB, Paredes J

P-cadherin signals through the laminin receptor a6ß4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells. Oncotarget 5: 679-92, 2014.  [Article] 

 PMID: 24553076.

 

20. Nunes JB, Peixoto J, Soares P, Maximo V, Carvalho S, Pinho SS, Vieira AF, Paredes J, Rego AC, Ferreira IL, Gomez-Lazaro M, Sobrinho-Simoes M, Singh KK, Lima J

OXPHOS dysfunction regulates integrin-ß1 modifications and enhances cell motility and migration. Human molecular genetics 24: 1977-90, 2015.  [Article] 

 doi: 10.1093/hmg/ddu612 PMID: 25504047.

 

21. Figueiredo J, Melo S, Carneiro P, Moreira AM, Fernandes MS, Ribeiro AS, Guilford P, Paredes J, Seruca R

Clinical spectrum and pleiotropic nature of CDH1 germline mutations. Journal of medical genetics 56: 199-208, 2019.  [Review] 

 doi: 10.1136/jmedgenet-2018-105807 PMID: 30661051.

 

22. Vieira AF, Paredes J

P-cadherin and the journey to cancer metastasis. Molecular cancer 14: 178, 2015.  [Review] 

 doi: 10.1186/s12943-015-0448-4 PMID: 26438065.

 

23. Lopes N, Paredes J, Costa JL, Ylstra B, Schmitt F

Vitamin D and the mammary gland: a review on its role in normal development and breast cancer. Breast cancer research : BCR 14: 211, 2012.  [Review] 

 doi: 10.1186/bcr3178 PMID: 22676419.

 

24. Paredes J, Albergaria A, Oliveira JT, Jerónimo C, Milanezi F, Schmitt FC

P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clinical cancer research : an official journal of the American Association for Cancer Research 11: 5869-77, 2005.  [Article] 

 doi: 10.1158/1078-0432.CCR-05-0059 PMID: 16115928.

 

25. Ribeiro AS, Sousa B, Carreto L, Mendes N, Ricardo S, Albergaria A, Cameselle-Teijeiro JF, Gerhard R, Soderberg O, Seruca R, Santos MA, Schmitt F, Paredes J

P-cadherin promotes cancer cell invasion by interference with E-cadherin suppressor function The FASEB Journal  1, 2011.  [] 

.

 

26. Corso G, Velho S, Paredes J, Pedrazzani C, Martins D, Milanezi F, Pascale V, Vindigni C, Pinheiro H, Leite M, Marrelli D, Sousa S, Carneiro F, Oliveira C, Roviello F, Seruca R

Oncogenic mutations in gastric cancer with microsatellite instability. European journal of cancer (Oxford, England : 1990) 47: 443-51, 2011.  [Article] 

 doi: 10.1016/j.ejca.2010.09.008 PMID: 20937558.

 

27. Albergaria A, Paredes J, Sousa B, Milanezi F, Carneiro V, Bastos J, Costa S, Vieira D, Lopes N, Lam EW, Lunet N, Schmitt F

Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast cancer research : BCR 11: 3, 2009.  [Article] 

 PMID: 19549328.

 

28. Ribeiro AS, Nobre AR, Mendes N, Almeida J, Vieira AF, Sousa B, Carvalho FA, Monteiro J, Polónia A, Fonseca M, Sanches JM, Santos NC, Seruca R, Paredes J

SRC inhibition prevents P-cadherin mediated signaling and function in basal-like breast cancer cells. Cell communication and signaling : CCS 16: 75, 2018.  [Article] 

 doi: 10.1186/s12964-018-0286-2 PMID: 30404626.

 

29. Carneiro P, Moreira AM, Figueiredo J, Barros R, Oliveira P, Fernandes MS, Ferro A, Almeida R, Oliveira C, Carneiro F, Schmitt F, Paredes J, Velho S, Seruca R

S100P is a molecular determinant of E-cadherin function in gastric cancer. Cell communication and signaling : CCS 17: 155, 2019.  [Article] 

 doi: 10.1186/s12964-019-0465-9 PMID: 31767037.

 

30. Morais-Santos F, Granja S, Miranda-Gonçalves V, Moreira AH, Queirós S, Vilaça JL, Schmitt FC, Longatto-Filho A, Paredes J, Baltazar F, Pinheiro C

Targeting lactate transport suppresses in vivo breast tumour growth. Oncotarget 6: 19177-89, 2015.  [Article] 

 doi: 10.18632/oncotarget.3910 PMID: 26203664.

 

31. Martins D, Beça FF, Sousa B, Baltazar F, Paredes J, Schmitt F

Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: Key events in the progression from an in situ to an invasive breast carcinoma. Cell cycle (Georgetown, Tex.) 12: 2684-90, 2013.  [Article] 

 doi: 10.4161/cc.25794 PMID: 23907124.

 

32. Morais-Santos F, Miranda-Gonçalves V, Pinheiro S, Vieira AF, Paredes J, Schmitt FC, Baltazar F, Pinheiro C

Differential sensitivities to lactate transport inhibitors of breast cancer cell lines. Endocrine-related cancer 21: 27-38, 2014.  [Article] 

 doi: 10.1530/ERC-13-0132 PMID: 24174370.

 

33. Paredes J, Correia AL, Ribeiro AS, Albergaria A, Milanezi F, Schmitt FC

P-cadherin expression in breast cancer: a review. Breast cancer research : BCR 9: 214, 2007.  [Review] 

 doi: 10.1186/bcr1774 PMID: 18001487.

 

34. Oliveira P, Carvalho J, Rocha S, Azevedo M, Reis I, Camilo V, Sousa B, Valente S, Paredes J, Almeida R, Huntsman D, Oliveira C

Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation. Scientific reports 6: 34860, 2016.  [Article] 

 doi: 10.1038/srep34860 PMID: 27721458.

 

35. Mestre T, Figueiredo J, Ribeiro AS, Paredes J, Seruca R, Sanches JM

Quantification of topological features in cell meshes to explore E-cadherin dysfunction. Scientific reports 6: 25101, 2016.  [Article] 

 doi: 10.1038/srep25101 PMID: 27151223.

 

36. Sousa B, Pereira J, Paredes J

The Crosstalk Between Cell Adhesion and Cancer Metabolism. International journal of molecular sciences 20: ., 2019.  [Review] 

 doi: 10.3390/ijms20081933 PMID: 31010154.

 

37. Paredes J, Correia AL, Ribeiro AS, Schmitt F

Expression of p120-catenin isoforms correlates with genomic and transcriptional phenotype of breast cancer cell lines. Cellular oncology : the official journal of the International Society for Cellular Oncology 29: 467-76, 2007.  [Article] 

 PMID: 18032823.

 

38. Figueiredo J, Rodrigues I, Ribeiro J, Fernandes MS, Melo S, Sousa B, Paredes J, Seruca R, Sanches JM

Geometric compensation applied to image analysis of cell populations with morphological variability: a new role for a classical concept. Scientific reports 8: 10266, 2018.  [Article] 

 doi: 10.1038/s41598-018-28570-z PMID: 29980764.

 

39. Bernardes N, Ribeiro AS, Abreu S, Vieira AF, Carreto L, Santos M, Seruca R, Paredes J, Fialho AM

High-throughput molecular profiling of a P-cadherin overexpressing breast cancer model reveals new targets for the anti-cancer bacterial protein azurin. The international journal of biochemistry & cell biology 50: 1-9, 2014.  [Article] 

 doi: 10.1016/j.biocel.2014.01.023 PMID: 24509127.

 

40. de Almeida BP, Vieira AF, Paredes J, Bettencourt-Dias M, Barbosa-Morais NL

Pan-cancer association of a centrosome amplification gene expression signature with genomic alterations and clinical outcome. PLoS computational biology 15: e1006832, 2019.  [Article] 

 doi: 10.1371/journal.pcbi.1006832 PMID: 30856170.

 

41. Carneiro P, Fernandes MS, Figueiredo J, Caldeira J, Carvalho J, Pinheiro H, Leite M, Melo S, Oliveira P, Simões-Correia J, Oliveira MJ, Carneiro F, Figueiredo C, Paredes J, Oliveira C, Seruca R

E-cadherin dysfunction in gastric cancer - Cellular consequences, clinical applications and open questions. FEBS letters 586: 2981-9, 2012.  [Review] 

 doi: 10.1016/j.febslet.2012.07.045 PMID: 22841718.

 

42. Pinheiro C, Albergaria A, Paredes J, Sousa B, Dufloth R, Vieira D, Schmitt F, Baltazar F

Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 56: 860-7, 2010.  [Article] 

 doi: 10.1111/j.1365-2559.2010.03560.x PMID: 20636790.

 

43. Bernardes N, Ribeiro AS, Abreu S, Mota B, Matos RG, Arraiano CM, Seruca R, Paredes J, Fialho AM

The bacterial protein azurin impairs invasion and FAK/Src signaling in P-cadherin-overexpressing breast cancer cell models. PloS one 8: e69023, 2013.  [Article] 

 doi: 10.1371/journal.pone.0069023 PMID: 23894398.

 

44. Albergaria A, Resende C, Nobre AR, Ribeiro AS, Sousa B, Machado JC, Seruca R, Paredes J, Schmitt F

CCAAT/enhancer binding protein ß (C/EBPß) isoforms as transcriptional regulators of the pro-invasive CDH3/P-cadherin gene in human breast cancer cells. PloS one 8: e55749, 2013.  [Article] 

 doi: 10.1371/journal.pone.0055749 PMID: 23405208.

 

45. van der Werf CS, Hsiao NH, Conroy S, Paredes J, Ribeiro AS, Sribudiani Y, Seruca R, Hofstra RM, Westers H, van Ijzendoorn SC

CLMP is essential for intestinal development, but does not play a key role in cellular processes involved in intestinal epithelial development. PloS one 8: e54649, 2013.  [Article] 

 doi: 10.1371/journal.pone.0054649 PMID: 23460781.

 

46. Sousa B, Ribeiro AS, Nobre AR, Lopes N, Martins D, Pinheiro C, Vieira AF, Albergaria A, Gerhard R, Schmitt F, Baltazar F, Paredes J

The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype. BMC cancer 14: 734, 2014.  [Article] 

 doi: 10.1186/1471-2407-14-734 PMID: 25269858.

 

47. Pinto C, Silva G, Ribeiro AS, Oliveira M, Garrido M, Bandeira VS, Nascimento A, Coroadinha AS, Peixoto C, Barbas A, Paredes J, Brito C, Alves PM

Evaluation of AAV-mediated delivery of shRNA to target basal-like breast cancer genetic vulnerabilities. Journal of biotechnology 300: 70-77, 2019.  [Article] 

 doi: 10.1016/j.jbiotec.2019.05.016 PMID: 31150679.

 

48. Lopes N, Sousa B, Martins D, Gomes M, Vieira D, Veronese LA, Milanezi F, Paredes J, Costa JL, Schmitt F

Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions. BMC cancer 10: 483, 2010.  [Article] 

 doi: 10.1186/1471-2407-10-483 PMID: 20831823.

 

49. Polónia A, Pinto R, Cameselle-Teijeiro JF, Schmitt FC, Paredes J

Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer. Journal of clinical pathology 70: 860-867, 2017.  [Article] 

 doi: 10.1136/jclinpath-2016-203990 PMID: 28373294.

 

50. Martins D, Sousa B, Lopes N, Gomes M, Veronese L, Albergaria A, Paredes J, Schmitt F

Molecular phenotypes of matched in situ and invasive components of breast carcinomas. Human pathology 42: 1438-46, 2011.  [Article] 

 doi: 10.1016/j.humpath.2010.08.024 PMID: 21450330.

 

51. Albergaria A, Ribeiro A S, Vieira AF, Sousa B, Nobre AR, Seruca R, Schmitt F, Paredes J

P-cadherin role in normal breast development and cancer. International Journal Dev Biology  811-822, 2011.  [Article] 

 doi: 10.1387/ijdb.113382aa.

 

52. Silva MR, Marques R, Sousa B, Sardao VA, Oliveira PJ, Paredes J

P-cadherin effect in mitochondrial dynamics and biogenesis of breast cancer cells European Journal of Clinical Investigation 49: 185-186, 2019.  [Meeting Abstract] 

.

 

53. Schmitt F, Ricardo S, Vieira AF, Dionísio MR, Paredes J

Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes. Virchows Archiv : an international journal of pathology 460: 545-53, 2012.  [Review] 

 doi: 10.1007/s00428-012-1237-8 PMID: 22562130.

 

54. Beça FF, Caetano P, Gerhard R, Alvarenga CA, Gomes M, Paredes J, Schmitt F

Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types. Journal of clinical pathology 66: 187-91, 2013.  [Article] 

 doi: 10.1136/jclinpath-2012-201169 PMID: 23112116.

 

55. Gama A, Paredes J, Milanezi MF, Reis-Filho JS, Gartner F, Schmitt FC

P-cadherin expression in canine lactating mammary gland. Journal of cellular biochemistry 86: 420-1, 2002.  [Letter] 

 doi: 10.1002/jcb.10245 PMID: 12210748.

 

56. Sousa B, Paredes J, Milanezi F, Lopes N, Martins D, Dufloth R, Vieira D, Albergaria A, Veronese L, Carneiro V, Carvalho S, Costa JL, Zeferino L, Schmitt F

P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study. Histology and histopathology 25: 963-74, 2010.  [Article] 

 PMID: 20552547.

 

57. Gerhard R, Ricardo S, Albergaria A, Gomes M, Silva AR, Logullo AF, Cameselle-Teijeiro JF, Paredes J, Schmitt F

Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas. Breast (Edinburgh, Scotland) 21: 354-60, 2012.  [Article] 

 doi: 10.1016/j.breast.2012.03.001 PMID: 22464177.

 

58. Pinheiro C, Sousa B, Albergaria A, Paredes J, Dufloth R, Vieira D, Schmitt F, Baltazar F

GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. Histology and histopathology 26: 1279-86, 2011.  [Article] 

 PMID: 21870331.

 

59. Zollinger AJ, Xu H, Figueiredo J, Paredes J, Seruca R, Stamenovic D, Smith ML

Dependence of Tensional Homeostasis on Cell Type and on Cell-Cell Interactions Cellular and Molecular Bioengineering 11: 175-184, 2018.  [Article] 

 doi: 10.1007/s12195-018-0527-x.

 

60. Paredes J, Correia AL, Ribeiro AS, Milanezi F, Cameselle-Teijeiro J, Schmitt FC

Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localization and poor patient survival. Journal of clinical pathology 61: 856-62, 2008.  [Article] 

 doi: 10.1136/jcp.2007.052704 PMID: 18381381.

 

61. Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. Journal of clinical pathology 64: 937-46, 2011.  [Article] 

 doi: 10.1136/jcp.2011.090456 PMID: 21680574.

 

62. Ricardo S, Gerhard R, Cameselle-Teijeiro JF, Schmitt F, Paredes J

Claudin expression in breast cancer: High or low, what to expect? Histology and histopathology 27: 1283-95, 2012.  [Article] 

 PMID: 22936447.

 

63. Sousa B, Ribeiro AS, Paredes J

Heterogeneity and Plasticity of Breast Cancer Stem Cells. Advances in experimental medicine and biology 1139: 83-103, 2019.  [Article; Book Chapter] 

 doi: 10.1007/978-3-030-14366-4_5 PMID: 31134496.

 

64. Paredes J, Milanezi F, Viegas L, Amendoeira I, Schmitt F

P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast. Virchows Archiv : an international journal of pathology 440: 16-21, 2002.  [Article] 

 PMID: 11942571.

 

65. Paredes J, Lopes N, Milanezi F, Schmitt FC

P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ. Virchows Archiv : an international journal of pathology 450: 73-80, 2007.  [Article] 

 doi: 10.1007/s00428-006-0334-y PMID: 17123107.

 

66. Gama A, Paredes J, Gärtner F, Alves A, Schmitt F

Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival. Veterinary journal (London, England : 1997) 177: 45-53, 2008.  [Article] 

 doi: 10.1016/j.tvjl.2007.05.024 PMID: 17631398.

 

67. Lopes N, Carvalho J, Durães C, Sousa B, Gomes M, Costa JL, Oliveira C, Paredes J, Schmitt F

1alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1 promoter demethylation Anticancer research  1, 2012.  [] 

 PMID: 22213313.

 

68. Reis-Filho JS, Cancela Paredes J, Milanezi F, Schmitt FC

Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast. Cancer 94: 2114-5; author reply 2115-6, 2002.  [Letter] 

 PMID: 11932917.

 

69. Reis-Filho JS, Milanezi F, Paredes J, Silva P, Pereira EM, Maeda SA, de Carvalho LV, Schmitt FC

Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 11: 1-8, 2003.  [Article; Proceedings Paper] 

 PMID: 12610349.

 

70. Gama A, Paredes J, Albergaria A, Gartner F, Schmitt F

P-cadherin expression in canine mammary tissues. Journal of comparative pathology 130: 13-20, 2004.  [Article] 

 PMID: 14693120.

 

71. de Matos Granja N, Soares R, Rocha S, Paredes J, Longatto Filho A, Alves VA, Wiley E, Schmitt FC, Bedrossian C

Evaluation of breast cancer metastases in pleural effusions by molecular biology techniques. Diagnostic cytopathology 27: 210-3, 2002.  [Article] 

 doi: 10.1002/dc.10171 PMID: 12357497.

 

72. Paredes J, Milanezi F, Reis-Filho JS, Leitão D, Athanazio D, Schmitt F

Aberrant P-cadherin expression: is it associated with estrogen-independent growth in breast cancer? Pathology, research and practice 198: 795-801, 2002.  [Article] 

 PMID: 12608656.

 

73. Longatto Filho A, Albergaria A, Paredes J, Moreira MA, Milanezi F, Schmitt FC

P-cadherin expression in glandular lesions of the uterine cervix detected by liquid-based cytology. Cytopathology : official journal of the British Society for Clinical Cytology 16: 88-93, 2005.  [Article] 

 doi: 10.1111/j.1365-2303.2004.00226.x PMID: 15787651.

 

74. Ribeiro AS, Paredes J

P-Cadherin Linking Breast Cancer Stem Cells and Invasion: A Promising Marker to Identify an "Intermediate/Metastable" EMT State. Frontiers in oncology 4: 371, 2014.  [Article] 

 doi: 10.3389/fonc.2014.00371 PMID: 25601904.

 

75. Paredes J, Albergaria A, Carvalho S, Schmitt F

"Basal-like" breast cancer carcinomas: Identification by P-cadherin, p63, EGFR and basal cytokeratins expression. Applied Cancer Research 26: 41-55, 2006.  [] 

.